LXRX vs TXN · rev $21.8M vs P/E 52, rev $10.29B
Lexicon Pharmaceuticals Inc (LXRX) versus Texas Instruments Incorporated (TXN) — a side-by-side from cached financials, not a winner call.
Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ. It is led by Haviv Ilan.
Latest reported LXRX revenue for 2026-06-30 was $21.8M. Net income was -$32.8M. Revenue was up 3.3% from 2026-03-31 to 2026-06-30. LXRX currently screens at market cap $327.2M.
Latest reported TXN revenue for 2026-06-30 was $10.29B. Net income was $3.52B. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
LXRX currently screens at market cap $327.2M. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Not investment advice. Open the LXRX and TXN stock pages for the full models.
Not investment advice.